Disease 指定難病
疾患数 : 338 - 臨床試験総数 : 34,520 / 薬物総数 : 19,957 - ( DrugBank : 2,195 ) / 標的遺伝子総数 : 613 - 標的パスウェイ総数 : 297
Showing 1 to 10 of 43 diseases
告示 番号 | 疾患名 [疾患群] | 臨床試験数 | Phase 1 / 2 / 3 / 4 | 薬物数 [ DrugBank ] | 標的遺伝子数 | パスウェイ数 | 国内患者数 医療費受給者証所持者数 (R5年度) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
19 | ライソゾーム病 [代] 💬 "Lysosomal storage disease", "Lysosomal disease", "Gaucher disease", "Niemann-Pick disease type A/B", "Niemann-Pick type A", "NPD-A", "NPA", "Niemann-Pick type B", "NPD-B", "NPB", "Acid sphingomyelinase deficiency", "ASMD", "Niemann-Pick disease type C", "Niemann-Pick type C", "NPD-C", "NPC", "GM1-gangliosidosis", "GM1-gangliosidoses", "GM2-gangliosidosis", "GM2-gangliosidoses", "Tay-Sachs disease", "Sandhoff disease", "Krabbe disease", "Metachromatic leukodystrophy", "MLD", "Multiple-sulfatase deficiency", "Farber disease", "Mucopolysaccharidosis type I", "Mucopolysaccharidosis I", "MPS I", "Hurler syndrome", "Hurler-Scheie syndrome", "Scheie syndrome", "Mucopolysaccharidosis type II", "Mucopolysaccharidosis II", "MPS II", "Hunter syndrome", "Mucopolysaccharidosis type III", "Mucopolysaccharidosis III", "MPS III", "Sanfilippo syndrome", "Mucopolysaccharidosis type IV", "Mucopolysaccharidosis IV", "MPS IV", "MPS IVA", "Morquio syndrome", "Morquio A syndrome", "Mucopolysaccharidosis type VI", "Mucopolysaccharidosis VI", "MPS VI", "Maroteaux-Lamy syndrome", "Mucopolysaccharidosis type VII", "Mucopolysaccharidosis VII", "MPS VII", "Sly syndrome", "Mucopolysaccharidosis type IX", "Mucopolysaccharidosis IX", "MPS IX", "Hyaluronidase deficiency", "Sialidosis", "Galactosialidosis", "Mucolipidosis II", "Mucolipidosis type II", "I-cell disease", "Mucolipidosis III", "Mucolipidosis type III", "Alpha-Mannosidosis", "Alpha-Mannosidase Deficiency", "Beta-Mannosidosis", "Beta-Mannosidase Deficiency", "Fucosidosis", "Aspartylglucosaminuria", "Schindler disease", "Kanzaki disease", "Pompe disease", "Acid lipase deficiency", "Wolman disease", "Cholesterol ester storage disease", "Danon disease", "Free sialic acid storage disease", "Infantile sialic acid storage disease", "ISSD", "Salla disease", "Ceroid lipofuscinosis", "Fabry disease", "Cystinosis" "Lysosomal storage disease", "Lysosomal disease", "Gaucher disease", "Niemann-Pick disease type A/B" ... 19. ライソゾーム病
| 899 899 trials | 549 / 383 / 342 / 126 💬 19. ライソゾーム病Some trials have no Phase data.
| 684 684 drugs [ 99 99 drugs ] | 51 51 genes | 182 pathways | 1756 1,756人年齢分布 ![]() 19. ライソゾーム病
| ||||||||||||||||||||||
20 | 副腎白質ジストロフィー [代] 💬 "Adrenoleukodystrophy", "ALD", "Childhood cerebral adrenoleukodystrophy", "Childhood cerebral ALD", "CCALD", "Adolescent cerebral adrenomyeloneuropathy", "AdolCALD", "Adrenomyeloneuropathy", "AMN", "Adult cerebral adrenoleukodystrophy", "ACALD", "Cerebellum-brain stem type adrenoleukodystrophy", "Addison-only adrenoleukodystrophy", "AO ALD", "Adrenoleukodystrophy (Female onset)" "Adrenoleukodystrophy", "ALD", "Childhood cerebral adrenoleukodystrophy", "Childhood cerebral ALD", ... 20. 副腎白質ジストロフィー
| 61 61 trials | 42 / 36 / 28 / 7 💬 20. 副腎白質ジストロフィーSome trials have no Phase data.
| 90 90 drugs [ 31 31 drugs ] | 23 23 genes | 126 pathways | 268 268人年齢分布 ![]() 20. 副腎白質ジストロフィー
| ||||||||||||||||||||||
21 | ミトコンドリア病 [代] 💬 "Mitochondrial disease" 21. ミトコンドリア病
| 39 39 trials | 7 / 21 / 15 / 2 💬 21. ミトコンドリア病Some trials have no Phase data.
| 42 42 drugs [ 32 32 drugs ] | 47 47 genes | 67 pathways | 1671 1,671人年齢分布 ![]() 21. ミトコンドリア病
| ||||||||||||||||||||||
28 | 全身性アミロイドーシス [代] 💬 "Systemic amyloidosis", "AL amyloidosis", "Immunoglobulin light chain amyloidosis", "Amyloid light-chain amyloidosis", "Immunoglobulin-related amyloidosis", "Reactive AA amyloidosis", "Senile transthyretin amyloidosis", "Senile TTR amyloidosis", "Senile systemic amyloidosis", "Familial amyloidosis", "Familial amyloid polyneuropathy", "FAP" "Systemic amyloidosis", "AL amyloidosis", "Immunoglobulin light chain amyloidosis", "Amyloid light-c ... 28. 全身性アミロイドーシス
| 267 267 trials | 82 / 116 / 111 / 11 💬 28. 全身性アミロイドーシスSome trials have no Phase data.
| 241 241 drugs [ 77 77 drugs ] | 68 68 genes | 180 pathways | 6817 6,817人年齢分布 ![]() 28. 全身性アミロイドーシス
| ||||||||||||||||||||||
79 | 家族性高コレステロール血症(ホモ接合体) [代] 💬 "Homozygous familial hypercholesterolemia" 79. 家族性高コレステロール血症(ホモ接合体)
| 145 145 trials | 51 / 42 / 94 / 10 💬 79. 家族性高コレステロール血症(ホモ接合体)Some trials have no Phase data.
| 114 114 drugs [ 26 26 drugs ] | 8 8 genes | 17 pathways | 413 413人年齢分布 ![]() 79. 家族性高コレステロール血症(ホモ接合体)
| ||||||||||||||||||||||
169 | メンケス病 [代] 💬 "Menkes disease" 169. メンケス病
| 6 6 trials | 2 / 2 / 1 / 0 💬 169. メンケス病Some trials have no Phase data.
| 6 6 drugs [ 4 4 drugs ] | 9 9 genes | 14 pathways | 2 2人年齢分布 ![]() 169. メンケス病
| ||||||||||||||||||||||
171 | ウィルソン病 [代] 💬 "Wilson disease", "WD" 171. ウィルソン病
| 79 79 trials | 42 / 24 / 32 / 15 💬 171. ウィルソン病Some trials have no Phase data.
| 77 77 drugs [ 17 17 drugs ] | 6 6 genes | 30 pathways | 779 779人年齢分布 ![]() 171. ウィルソン病
| ||||||||||||||||||||||
234 | ペルオキシソーム病(副腎白質ジストロフィーを除く。) [代] 💬 "Peroxisomal disease (except Adrenoleukodystrophy)", "Peroxisomal disease", "Peroxisomal disorder", "Peroxisome biogenesis disorder", "PEX gene disorder", "Zellweger syndrome", "Neonatal adrenoleukodystrophy", "Infantile Refsum disease", "Rhizomelic chondrodysplasia punctata type 1", "RCDP type 1", "RCDP1", "Peroxisomal beta-oxidation enzyme deficiency", "Acyl-CoA oxidase deficiency", "AOX deficiency", "D-Bifunctional protein deficiency", "DBP deficiency", "Sterol carrier protein X deficiency", "SCPx deficiency", "2-methylacyl-CoA racemase deficiency", "Alpha-methylacyl-CoA racemase deficiency", "AMACR deficiency", "Plasmalogen biosynthesis enzyme deficiency", "Rhizomelic chondrodysplasia punctata type 2", "RCDP type 2", "RCDP2", "Rhizomelic chondrodysplasia punctata type 3", "RCDP type 3", "RCDP3", "Refsum disease", "Primary hyperoxaluria type 1", "PH1", "Acatalasemia", "Acatalasia", "Takahara disease", "Contiguous ABCD1/DXS1357E deletion syndrome", "CADDS" "Peroxisomal disease (except Adrenoleukodystrophy)", "Peroxisomal disease", "Peroxisomal disorder", ... 234. ペルオキシソーム病(副腎白質ジストロフィーを除く。)
| 39 39 trials | 30 / 21 / 18 / 5 💬 234. ペルオキシソーム病(副腎白質ジストロフィーを除く。)Some trials have no Phase data.
| 35 35 drugs [ 12 12 drugs ] | 13 13 genes | 45 pathways | 3 3人年齢分布 ![]() 234. ペルオキシソーム病(副腎白質ジストロフィーを除く。)
| ||||||||||||||||||||||
240 | フェニルケトン尿症 [代] 💬 "Phenylketonuria", "PKU", "Phenylalanine hydroxylase deficiency", "PAH deficiency", "Tetrahydrobiopterin deficiency", "BH4 deficiency", "BH4 reactive hyper pheemia" "Phenylketonuria", "PKU", "Phenylalanine hydroxylase deficiency", "PAH deficiency", "Tetrahydrobiopt ... 240. フェニルケトン尿症
| 143 143 trials | 79 / 31 / 43 / 26 💬 240. フェニルケトン尿症Some trials have no Phase data.
| 90 90 drugs [ 10 10 drugs ] | 1 1 gene | 5 pathways | 298 298人年齢分布 ![]() 240. フェニルケトン尿症
| ||||||||||||||||||||||
241 | 高チロシン血症1型 [代] 💬 "Hypertyrosinemia type I", "Tyrosinemia type I", "Tyrosinemia I", "Hereditary tyrosinemia, Type I", "Fumarylacetoacetate hydrolase deficiency", "FAH deficiency", "Acute hypertyrosinemia type I", "Acute tyrosinemia type I", "Acute tyrosinemia I", "Subacute hypertyrosinemia type I", "Subacute tyrosinemia type I", "Subacute tyrosinemia I", "Chronic hypertyrosinemia type I", "Chronic tyrosinemia type I", "Chronic tyrosinemia I" "Hypertyrosinemia type I", "Tyrosinemia type I", "Tyrosinemia I", "Hereditary tyrosinemia, Type I", ... 241. 高チロシン血症1型
| 14 14 trials | 4 / 1 / 1 / 1 💬 241. 高チロシン血症1型Some trials have no Phase data.
| 7 7 drugs [ 1 1 drug ] | 1 1 gene | 5 pathways | 3 3人年齢分布 ![]() 241. 高チロシン血症1型
|